SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-003060
Filing Date
2024-03-13
Accepted
2024-03-13 08:43:34
Documents
122
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F tmb-20231231x20f.htm   iXBRL 20-F 3931147
2 EX-8.1 tmb-20231231xex8d1.htm EX-8.1 8279
3 EX-12.1 tmb-20231231xex12d1.htm EX-12.1 13569
4 EX-12.2 tmb-20231231xex12d2.htm EX-12.2 13489
5 EX-13.1 tmb-20231231xex13d1.htm EX-13.1 17067
6 EX-15.1 tmb-20231231xex15d1.htm EX-15.1 3049
7 EX-97.1 tmb-20231231xex97d1.htm EX-97.1 37484
8 GRAPHIC tmb-20231231x20f001.jpg GRAPHIC 94773
9 GRAPHIC tmb-20231231x20f002.jpg GRAPHIC 52334
10 GRAPHIC tmb-20231231x20f003.jpg GRAPHIC 81295
11 GRAPHIC tmb-20231231x20f004.jpg GRAPHIC 61797
  Complete submission text file 0001558370-24-003060.txt   14829586

Data Files

Seq Description Document Type Size
12 EX-101.SCH tmb-20231231.xsd EX-101.SCH 109204
13 EX-101.CAL tmb-20231231_cal.xml EX-101.CAL 84679
14 EX-101.DEF tmb-20231231_def.xml EX-101.DEF 324241
15 EX-101.LAB tmb-20231231_lab.xml EX-101.LAB 696124
16 EX-101.PRE tmb-20231231_pre.xml EX-101.PRE 545318
124 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20231231x20f_htm.xml XML 2877429
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36622 | Film No.: 24744674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)